SCHEMBL16410679

SCHEMBL16410679

Clc1cccc(CNNC2=Nc3ccccc3NC23CNC3)c1

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ACAT2 Q9BWD1 1/20 0.40
▸ KMT2A Q03164 2/20 0.34
▸ CHRM2 P08172 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ C3AR1 Q16581 1/20 0.33
▸ MAOB P27338 3/20 0.32
▸ HTR6 P50406 3/20 0.32
▸ SLC6A4 P31645 1/20 0.32
▸ NOS3 P29474 1/20 0.32
▸ NOS1 P29475 1/20 0.32
▸ NOS2 P35228 1/20 0.32
▸ GSK3B P49841 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ APP P05067 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16410840 0.91 ACAT2 (0.42) ACAT2KMT2ACHRM2KDM4EHTT
SCHEMBL17757493 0.89 ACAT2 (0.42) ACAT2KMT2AC3AR1MAOBHTR6
SCHEMBL16410606 0.88 ACAT2 (0.40) ACAT2KMT2ACHRM2KDM4EHTT
SCHEMBL17757041 0.85 ACAT2 (0.43) ACAT2KMT2AC3AR1MAOBHTR6
SCHEMBL16410633 0.85 ACAT2 (0.37) ACAT2KMT2AKDM4EMAOBHTR6
SCHEMBL16410598 0.83 ACAT2 (0.36) ACAT2KMT2ACHRM2KDM4ENOS3
SCHEMBL16410773 0.83 ACAT2 (0.36) ACAT2KMT2AKDM4EHTTNOS3
SCHEMBL16410769 0.83 ACAT2 (0.36) ACAT2KMT2AKDM4EHTTNOS3
SCHEMBL16410817 0.81 ACAT2 (0.33) ACAT2KMT2AHTTC3AR1NOS3
SCHEMBL16410753 0.81 ACAT2 (0.35) ACAT2KMT2AKDM4EHTTNOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015007730-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2015-01-22 — — WO disclosed
Send feedback